Transcatheter Device Closure of Perimembranous Ventricular Septal Defect in Pediatric Patients: Long-Term Outcomes

Jayal Hasmukhbhai Shah, Sanket Pravinchandra Saraiya, Tushar Sudhakarrao Nikam, Mukesh Jitendra Jha, Jayal Hasmukhbhai Shah, Sanket Pravinchandra Saraiya, Tushar Sudhakarrao Nikam, Mukesh Jitendra Jha

Abstract

Aims: The aim of this study is to evaluate the safety and efficacy of transcatheter device closure of perimembranous ventricular septal defects in pediatric patients at long-term follow-up.

Materials and methods: We prospectively studied 376 patients with perimembranous VSDs between September 2008 and December 2015 who underwent percutaneous closure at our center. Transthoracic echocardiography (TTE) and electrocardiogram were done before and after the procedure in all the patients. All patients were subjected to follow-up evaluation at 1, 3, 6, 12 months, and annually thereafter with TTE and electrocardiogram.

Results: A total of 376 patients (210 males and 166 females) underwent transcatheter closure of perimembranous VSD. Mean age of patients was 8.67 ± 3.02 (range 3-18 years) and mean weight was 21.15 ± 8.31 (range 8-65 kg). The procedure was carried out successfully in 98.93% of patients with no reported mortality. Rhythm disturbances occurred in 8.5% of patients after the procedure which included three cases of complete atrioventricular block.

Conclusion: This study shows that in experienced hands transcatheter closure of perimembrnous VSD is safe and effective at long-term follow-up. With minimal morbidity and no mortality, the transcatheter is an effective alternative to surgical closure in selected patients.

Keywords: Long-term follow-up; pediatric patients; perimembranous ventricular septal defects; transcatheter closure.

Conflict of interest statement

There are no conflicts of interest.

Copyright: © 2020 Heart Views.

References

    1. Minette MS, Sahn DJ. Ventricular septal defects. Circulation. 2006;114:2190–7.
    1. Mavroudis C, Backer CL, Jacobs JP. Pediatric Cardiac Surgery. 3rd ed. Philadelphia, PA: Mosby; 2003. Ventricular septal defect; pp. 298–320.
    1. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, Van Domburg R, Van Rijen EH, Utens EM, et al. Outcome of patients after surgical closure of ventricular septal defect at young age: Longitudinal follow-up of 22-34 years. Eur Heart J. 2004;25:1057–62.
    1. Hobbins SM, Izukawa T, Radford DJ, Williams WG, Trusler GA. Conduction disturbances after surgical correction of ventricular septal defect by the atrial approach. Br Heart J. 1979;41:289–93.
    1. Kirklin JW, Barrat-Boyes BG. Ventricular septal defect. In: Kouchoukos NT, Blacksgowe EH, Doty DB, Hawley FL, Karp RB, editors. Cardiac Surgery. 3rd ed. New York: Churchill Livingstone; 1993. pp. 850–910.
    1. Yeager SB, Freed MD, Keane JF, Norwood WI, Castaneda AR. Primary surgical closure of ventricular septal defect in the first year of life: Results in 128 infants. J Am Coll Cardiol. 1984;3:1269–76.
    1. Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M, Bogers AJ. Follow-up after surgical closure of congenital ventricular septal defect. Eur J Cardiothorac Surg. 2003;24:511–5.
    1. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988;78:361–8.
    1. Bridges ND, Perry SB, Keane JF, Goldstein SA, Mandell V, Mayer JE, Jr, et al. Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med. 1991;324:1312–7.
    1. Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of ventricular septal defects: Immediate results and intermediate-term follow-up. Am Heart J. 1999;138:339–44.
    1. Pedra CA, Pedra SR, Esteves CA, Pontes SC, Jr, Braga SL, Arrieta SR, et al. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: Technical and morphological considerations. Catheter Cardiovasc Interv. 2004;61:403–10.
    1. Butera G, Carminati M, Chessa M, Piazza L, Abella R, Negura DG, et al. Percutaneous closure of ventricular septal defects in children aged<12: Early and mid-term results. Eur Heart J. 2006;27:2889–95.
    1. Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, et al. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder: Immediate and midterm results of an international registry. Catheter Cardiovasc Interv. 2006;68:620–8.
    1. Thanopoulos BV, Rigby ML, Karanasios E, Stefanadis C, Blom N, Ottenkamp J, et al. Transcatheter closure of perimembranous ventricular septal defects in infants and children using the Amplatzer perimembranous ventricular septal defect occluder. Am J Cardiol. 2007;99:984–9.
    1. Xunmin C, Shisen J, Jianbin G, Haidong W, Lijun W. Comparison of results and complications of surgical and Amplatzer device closure of perimembranous ventricular septal defects. Int J Cardiol. 2007;120:28–31.
    1. Qin Y, Chen J, Zhao X, Liao D, Mu R, Wang S, et al. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol. 2008;101:1781–6.
    1. Hijazi ZM, Hakim F, Haweleh AA, Madani A, Tarawna W, Hiari A, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Initial clinical experience. Catheter Cardiovasc Interv. 2002;56:508–15.
    1. Knauth AL, Lock JE, Perry SB, McElhinney DB, Gauvreau K, Landzberg MJ, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation. 2004;110:501–7.
    1. Fu YC, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE, et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: Results of the U.S. phase I trial. J Am Coll Cardiol. 2006;47:319–25.
    1. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. Cardiol Young. 2007;17:243–53.
    1. Chessa M, Butera G, Negura D, Bussadori C, Giamberti A, Fesslova V, et al. Transcatheter closure of congenital ventricular septal defects in adult: Mid-term results and complications. Int J Cardiol. 2009;133:70–3.
    1. Zhou T, Shen XQ, Zhou SH, Fang ZF, Hu XQ, Zhao YS, et al. Complications associated with transcatheter closure of perimembranous ventricular septal defects. Catheter Cardiovasc Interv. 2008;71:559–63.
    1. Zheng Q, Zhao Z, Zuo J, Yang J, Wang H, Yu S, et al. A comparative study: Early results and complications of percutaneous and surgical closure of ventricular septal defect. Cardiology. 2009;114:238–43.
    1. Masura J, Gao W, Gavora P, Sun K, Zhou AQ, Jiang S, et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: Multicenter follow-up study. Pediatr Cardiol. 2005;26:216–9.
    1. Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol. 2005;96:52L–8L.
    1. Bass JL, Kalra GS, Arora R, Masura J, Gavora P, Thanopoulos BD, et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv. 2003;58:238–45.
    1. Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the rashkind device: Initial experience. Catheter Cardiovasc Interv. 1999;46:43–8.
    1. Vogel M, Rigby ML, Shore D. Perforation of the right aortic valve cusp: Complication of ventricular septal defect closure with a modified Rashkind umbrella. Pediatr Cardiol. 1996;17:416–8.
    1. Gu X, Han YM, Titus JL, Amin Z, Berry JM, Kong H, et al. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter Cardiovasc Interv. 2000;50:502–9.
    1. Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer muscular VSD occluder: Initial results and technical considerations. Catheter Cardiovasc Interv. 2000;49:167–72.
    1. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder: Initial clinical applications in children. J Am Coll Cardiol. 1999;33:1395–9.
    1. Tan CA, Levi DS, Moore JW. Percutaneous closure of perimembranous ventricular septal defect associated with a ventricular septal aneurysm using the Amplatzer ductal occluder. Catheter Cardiovasc Interv. 2005;66:427–31.
    1. Sullivan ID. Transcatheter closure of perimembranous ventricular septal defect: Is the risk of heart block too high a price? Heart. 2007;93:284–6.
    1. Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, et al. Transcatheter closure of congenital ventricular septal defects: Results of the European registry. Eur Heart J. 2007;28:2361–8.
    1. Hammon JW., Jr Myocardial protection in the immature heart. Ann Thorac Surg. 1995;60:839–42.
    1. Yip WC, Zimmerman F, Hijazi ZM. Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect. Catheter Cardiovasc Interv. 2005;66:436–41.
    1. Walsh MA, Bialkowski J, Szkutnik M, Pawelec-Wojtalik M, Bobkowski W, Walsh KP. Atrioventricular block after transcatheter closure of perimembranous ventricular septal defects. Heart. 2006;92:1295–7.
    1. Yalonetsky S, Lorber A. Late high degree atrioventricular block after percutaneous closure of a perimembranous ventricular septal defect. Cardiol Young. 2009;19:298–300.
    1. Chen H, Liu J, Gao W, Hong H. Late complete atrioventricular block and tricuspid regurgitation after percutaneous closure of a perimembranous ventricular septal defect. J Thorac Cardiovasc Surg. 2010;140:e60–1.
    1. Butera G, Carminati M, Chessa M, Piazza L, Micheletti A, Negura DG, et al. Transcatheter closure of perimembranous ventricular septal defects: Early and long-term results. J Am Coll Cardiol. 2007;50:1189–95.
    1. Butera G, Massimo C, Mario C. Late complete atriovenous block after percutaneous closure of a perimembranous ventricular septal defect. Catheter Cardiovasc Interv. 2006;67:938–41.
    1. Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008;136:1223–8.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe